Dr. Charles C. Te, MD
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Oklahoma College of Medicine (2007)
- Years since graduation
- 19
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 2,152
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Medical school: University of Oklahoma College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
OK license 25661 -
Cardiovascular Disease Physician
OK license 25661 -
Internal Medicine Physician
OK license 25661 -
Nuclear Cardiology Physician
OK license 25661
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- O U Medical Center Oklahoma City, OK
- Integris Baptist Medical Center, Inc Oklahoma City, OK
- Mercy Hospital Oklahoma City, Inc Oklahoma City, OK
- Oklahoma Heart Hospital, LLC Oklahoma City, OK
- Oklahoma Heart Hospital South, LLC Oklahoma City, OK
Medical groups
- Ohh Physicians LLC (133 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,152
- Services billed
- 7,376
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 1,745 | 781 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 1,044 | 334 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 767 | 572 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 644 | 245 |
| Programming of dual lead pacemaker system | 508 | 448 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 411 | 168 |
| Established patient office or other outpatient visit, 30-39 minutes | 248 | 238 |
| New patient office or other outpatient visit, 60-74 minutes | 193 | 193 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 123 | 96 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 113 | 94 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Flecainide Acetate Other prescribers in Oklahoma City, OK | 699 |
| Eliquis (apixaban) Other prescribers in Oklahoma City, OK | 648 |
| Amiodarone Hcl Other prescribers in Oklahoma City, OK | 293 |
| Metoprolol Succinate Other prescribers in Oklahoma City, OK | 125 |
| Dofetilide | 99 |
| Xarelto (rivaroxaban) Other prescribers in Oklahoma City, OK | 89 |
| Sotalol (sotalol hcl) Other prescribers in Oklahoma City, OK | 61 |
| Metoprolol Tartrate Other prescribers in Oklahoma City, OK | 58 |
| Mexiletine Hcl | 39 |
| Diltiazem 24hr Er (Cd) (diltiazem hcl) Other prescribers in Oklahoma City, OK | 39 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 12 payments worth $444 in total to this clinician.
| Medtronic, Inc. | $182 |
|---|---|
| Biosense Webster, Inc. | $174 |
| Pfizer Inc. | $44.37 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $43.32 |
| Food and Beverage | $444 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $4,030 in research payments for these studies, mostly to the institutions running them.
- Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy
Impulse Dynamics (USA) Inc. · Active, not recruiting · NCT03970343
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.